These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20566437)

  • 41. Low swelling, crosslinked guar and its potential use as colon-specific drug carrier.
    Gliko-Kabir I; Yagen B; Penhasi A; Rubinstein A
    Pharm Res; 1998 Jul; 15(7):1019-25. PubMed ID: 9688054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binders for colon specific drug delivery: an in vitro evaluation.
    Sinha VR; Kumria R
    Int J Pharm; 2002 Dec; 249(1-2):23-31. PubMed ID: 12433431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-fluorouracil loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro release.
    Kaushik D; Sardana S; Mishra DN
    Yao Xue Xue Bao; 2009 Nov; 44(11):1278-84. PubMed ID: 21351727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tabletted guar gum microspheres of piroxicam for targeted adjuvant therapy for colonic adenocarcinomas.
    Vats A; Pathak K
    Ther Deliv; 2012 Nov; 3(11):1281-95. PubMed ID: 23259249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budesonide-loaded guar gum microspheres for colon delivery: preparation, characterization and in vitro/in vivo evaluation.
    Liu Y; Zhou H
    Int J Mol Sci; 2015 Jan; 16(2):2693-704. PubMed ID: 25629228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of tinidazole in healthy human volunteers.
    Krishnaiah YS; Muzib YI; Bhaskar P; Satyanarayana V; Latha K
    Drug Deliv; 2003; 10(4):263-8. PubMed ID: 14612342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride.
    Krishnaiah YS; Karthikeyan RS; Gouri Sankar V; Satyanarayana V
    J Control Release; 2002 May; 81(1-2):45-56. PubMed ID: 11992677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo evaluation of guar gum matrix tablets for oral controlled release of water-soluble diltiazem hydrochloride.
    Al-Saidan SM; Krishnaiah YS; Patro SS; Satyanaryana V
    AAPS PharmSciTech; 2005 Jul; 6(1):E14-21. PubMed ID: 16353958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and in vitro evaluation of a bipolymeric delivery device for the amelioration of colonic diseases using a popular glucocorticoid as a model drug.
    De Amit K; Datta S; Mukherjee A
    Acta Pol Pharm; 2011; 68(5):735-44. PubMed ID: 21928719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
    Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A
    Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective of guar gum and its derivatives as controlled drug delivery systems.
    Prabaharan M
    Int J Biol Macromol; 2011 Aug; 49(2):117-24. PubMed ID: 21596058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential of guar gum microspheres for target specific drug release to colon.
    Chourasia MK; Jain SK
    J Drug Target; 2004; 12(7):435-42. PubMed ID: 15621668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purified guar galactomannan as an improved pharmaceutical excipient.
    Gebert MS; Friend DR
    Pharm Dev Technol; 1998 Aug; 3(3):315-23. PubMed ID: 9742552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
    Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
    J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigation of colon-specific dosage forms of ondansetron prepared with natural polymers.
    Tuğcu-Demiröz F; Acartürk F; Takka S
    Pharmazie; 2006 Nov; 61(11):916-9. PubMed ID: 17152983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of polysaccharide-based colon targeted drug delivery systems for the treatment of amoebiasis.
    Mundargi RC; Patil SA; Agnihotri SA; Aminabhavi TM
    Drug Dev Ind Pharm; 2007 Mar; 33(3):255-64. PubMed ID: 17454058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.